HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong-Yi Zheng Selected Research

Disease Progression

3/2021Lower respiratory tract samples are reliable for severe acute respiratory syndrome coronavirus 2 nucleic acid diagnosis and animal model study.
8/2015High immune activation and abnormal expression of cytokines contribute to death of SHIV89.6-infected Chinese rhesus macaques.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong-Yi Zheng Research Topics

Disease

9Infections
03/2024 - 08/2015
6COVID-19
01/2023 - 12/2020
3Acquired Immunodeficiency Syndrome (AIDS)
03/2024 - 01/2017
2Disease Progression
03/2021 - 08/2015
2Inflammation (Inflammations)
09/2020 - 01/2018
1HIV Infections (HIV Infection)
05/2024
1Viremia
03/2024
1Pain (Aches)
07/2023
1Cognitive Dysfunction
12/2022
1Stroke (Strokes)
12/2022
1Chronic Disease (Chronic Diseases)
11/2022
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2022
1Fatigue
11/2022
1Immune System Diseases (Immune Disorders)
01/2022
1Pneumonia (Pneumonitis)
12/2021
1Mitochondrial Diseases (Mitochondrial Disease)
12/2021
1Body Weight (Weight, Body)
07/2021
1Hypertrophy
07/2021
1Cardiomegaly (Heart Hypertrophy)
07/2021
1Vesicular Stomatitis
01/2021
1Convalescence
12/2020
1Diarrhea
01/2018

Drug/Important Bio-Agent (IBA)

3Antiviral Agents (Antivirals)IBA
01/2023 - 09/2020
3Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2018
3InterferonsIBA
01/2023 - 01/2018
2VaccinesIBA
11/2022 - 08/2015
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 01/2018
2CytokinesIBA
01/2018 - 08/2015
1SARS-CoV-2 envelope proteinIBA
01/2023
1Interferon-alpha (Interferon Alfa)IBA
01/2023
1sinovac COVID-19 vaccineIBA
11/2022
1Inactivated VaccinesIBA
11/2022
1Neutralizing AntibodiesIBA
11/2022
1Immunologic Factors (Immunomodulators)IBA
12/2021
1Claudin-3IBA
12/2021
1GalactosidasesIBA
12/2021
1Tight Junction ProteinsIBA
12/2021
1Fatty Acid-Binding ProteinsIBA
12/2021
1Caspase 3 (Caspase-3)IBA
12/2021
1Claudin-1IBA
12/2021
1gastrodinIBA
07/2021
1Angiotensin IIIBA
07/2021
1Insulin-Like PeptidesIBA
07/2021
1AntibodiesIBA
03/2021
1Nucleic AcidsIBA
03/2021
1Immunoglobulin M (IgM)IBA
03/2021
1Immunoglobulin G (IgG)IBA
03/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1ParaffinIBA
01/2021
1NF-kappa B (NF-kB)IBA
01/2021
1Formaldehyde (Formol)FDA Link
01/2021
1Chemokine ReceptorsIBA
01/2021
1Glycoproteins (Glycoprotein)IBA
01/2021
1Interferon Type IIBA
12/2020
1RNA (Ribonucleic Acid)IBA
12/2020
1MicroRNAs (MicroRNA)IBA
12/2020
1Sialic Acid Binding Immunoglobulin-like LectinsIBA
01/2018
1HLA-A11 AntigenIBA
01/2017
1Protein Isoforms (Isoforms)IBA
01/2017

Therapy/Procedure

7Therapeutics
05/2024 - 08/2015
1Highly Active Antiretroviral Therapy (HAART)
03/2024
1Acupuncture Therapy
12/2022
1Acupuncture Points (Acupuncture Point)
12/2022
1Off-Label Use
12/2021
1Oral Administration
07/2021